Advances in Nanotechnology for Cancer Immunoprevention and Immunotherapy: A Review
One of the most effective cancer therapies, cancer immunotherapy has produced outstanding outcomes in the field of cancer treatment. However, the cost is excessive, which limits its applicability. A smart way to address this issue would be to apply the knowledge gained through immunotherapy to devel...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2022-10-01
|
| Series: | Vaccines |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2076-393X/10/10/1727 |
| _version_ | 1827647775517442048 |
|---|---|
| author | Navami Prabhakar Koyande Rupali Srivastava Ananya Padmakumar Aravind Kumar Rengan |
| author_facet | Navami Prabhakar Koyande Rupali Srivastava Ananya Padmakumar Aravind Kumar Rengan |
| author_sort | Navami Prabhakar Koyande |
| collection | DOAJ |
| description | One of the most effective cancer therapies, cancer immunotherapy has produced outstanding outcomes in the field of cancer treatment. However, the cost is excessive, which limits its applicability. A smart way to address this issue would be to apply the knowledge gained through immunotherapy to develop strategies for the immunoprevention of cancer. The use of cancer vaccines is one of the most popular methods of immunoprevention. This paper reviews the technologies and processes that support the advantages of cancer immunoprevention over traditional cancer immunotherapies. Nanoparticle drug delivery systems and nanoparticle-based nano-vaccines have been employed in the past for cancer immunotherapy. This paper outlines numerous immunoprevention strategies and how nanotechnology can be applied in immunoprevention. To comprehend the non-clinical and clinical evaluation of these cancer vaccines through clinical studies is essential for acceptance of the vaccines. |
| first_indexed | 2024-03-09T19:24:20Z |
| format | Article |
| id | doaj.art-d242626c93e044f1afb835c488ffb5fa |
| institution | Directory Open Access Journal |
| issn | 2076-393X |
| language | English |
| last_indexed | 2024-03-09T19:24:20Z |
| publishDate | 2022-10-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Vaccines |
| spelling | doaj.art-d242626c93e044f1afb835c488ffb5fa2023-11-24T03:05:00ZengMDPI AGVaccines2076-393X2022-10-011010172710.3390/vaccines10101727Advances in Nanotechnology for Cancer Immunoprevention and Immunotherapy: A ReviewNavami Prabhakar Koyande0Rupali Srivastava1Ananya Padmakumar2Aravind Kumar Rengan3Department of Biomedical Engineering, Indian Institute of Technology Hyderabad, Kandi, Sangareddy 502285, IndiaDepartment of Biomedical Engineering, Indian Institute of Technology Hyderabad, Kandi, Sangareddy 502285, IndiaDepartment of Biomedical Engineering, Indian Institute of Technology Hyderabad, Kandi, Sangareddy 502285, IndiaDepartment of Biomedical Engineering, Indian Institute of Technology Hyderabad, Kandi, Sangareddy 502285, IndiaOne of the most effective cancer therapies, cancer immunotherapy has produced outstanding outcomes in the field of cancer treatment. However, the cost is excessive, which limits its applicability. A smart way to address this issue would be to apply the knowledge gained through immunotherapy to develop strategies for the immunoprevention of cancer. The use of cancer vaccines is one of the most popular methods of immunoprevention. This paper reviews the technologies and processes that support the advantages of cancer immunoprevention over traditional cancer immunotherapies. Nanoparticle drug delivery systems and nanoparticle-based nano-vaccines have been employed in the past for cancer immunotherapy. This paper outlines numerous immunoprevention strategies and how nanotechnology can be applied in immunoprevention. To comprehend the non-clinical and clinical evaluation of these cancer vaccines through clinical studies is essential for acceptance of the vaccines.https://www.mdpi.com/2076-393X/10/10/1727cancer immunotherapycancer vaccinesimmunomodulationclinical trialstumor antigens |
| spellingShingle | Navami Prabhakar Koyande Rupali Srivastava Ananya Padmakumar Aravind Kumar Rengan Advances in Nanotechnology for Cancer Immunoprevention and Immunotherapy: A Review Vaccines cancer immunotherapy cancer vaccines immunomodulation clinical trials tumor antigens |
| title | Advances in Nanotechnology for Cancer Immunoprevention and Immunotherapy: A Review |
| title_full | Advances in Nanotechnology for Cancer Immunoprevention and Immunotherapy: A Review |
| title_fullStr | Advances in Nanotechnology for Cancer Immunoprevention and Immunotherapy: A Review |
| title_full_unstemmed | Advances in Nanotechnology for Cancer Immunoprevention and Immunotherapy: A Review |
| title_short | Advances in Nanotechnology for Cancer Immunoprevention and Immunotherapy: A Review |
| title_sort | advances in nanotechnology for cancer immunoprevention and immunotherapy a review |
| topic | cancer immunotherapy cancer vaccines immunomodulation clinical trials tumor antigens |
| url | https://www.mdpi.com/2076-393X/10/10/1727 |
| work_keys_str_mv | AT navamiprabhakarkoyande advancesinnanotechnologyforcancerimmunopreventionandimmunotherapyareview AT rupalisrivastava advancesinnanotechnologyforcancerimmunopreventionandimmunotherapyareview AT ananyapadmakumar advancesinnanotechnologyforcancerimmunopreventionandimmunotherapyareview AT aravindkumarrengan advancesinnanotechnologyforcancerimmunopreventionandimmunotherapyareview |